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Background: There is limited evidence about surgical outcomes after lumbar spinal surgery in 
patients with neuropathic pain (NP) or the prevalence of NP proportions among patients with 
degenerative lumbar diseases who are candidates for a surgical interventions.
Objective: The objectives of this study were to investigate the prevalence of NP among patients 
scheduled for lumbar spinal surgery and the relationship between health-related quality of life 
(HRQoL) and NP. This study also aimed to identify the risk factors related to NP and compare the 
clinical outcomes after surgical treatment between patients with and without NP.
Study Design: This study was a nationwide, multicenter, prospective, and observational study. It 
was conducted from September 2011 to May 2013, and included a total of 1,109 patients who were 
scheduled for lumbar spinal surgery from 44 spinal centers (both orthopedics and neurosurgeons). 
Setting: Multicenter study
Methods: Patients were diagnosed of having NP if the Leeds Assessment of Neuropathic 
Symptoms and Signs (LANSS) pain scale was ≥ 12 points. The patients were investigated to assess 
the differences in their clinical outcomes one week and 3 months after surgery and were followed-
up with regards to pain and HRQoL to explore the risk factors affecting NP.
Results: Of 1,109 recruited patients, 404 (36.4%) suffered from NP (mean age 62.06 years; 37.9% 
men) with mean LANSS score of 17.44 ± 4.06, while 705 (63.6%) had nociceptive pain with mean 
LANSS score of 6.03 ± 3.52. At baseline, patients with NP showed lower HRQoL and more severe 
pain compared to nociceptive pain patients. However, 3 months after surgical treatment, the NP 
group showed greater improvement in pain NRS (P = 0.087) and EQ-5D (P = 0.029) as compared to 
nociceptive pain group. Longer symptom duration was identified as a risk factor for NP (OR 1.003, 
respectively, P = 0.020). 
Conclusion: There was a high prevalence of NP in Korean patients scheduled for lumbar spine 
surgery, and these patients suffered greater pain and lower HRQoL than nociceptive pain patients. 
The more remarkable improvement NP patients showed after treatment highlights the importance 
of appropriate diagnosis and treatment of NP.
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The number of surgical interventions of the spine has increased yearly by 77% between 1996 and 2001 in the United States and this increased 
demand for costly surgical procedures represents a 
challenge for any health care system (1). Although 
there are numerous studies in this area, surgical 
decision-making for degenerative lumbar diseases 
such as intervertebral disc herniation, spinal stenosis, 
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1,109 patients were enrolled and completed the whole 
process without dropout from 44 participating spinal 
centers (both orthopedics and neurosurgeons) in Ko-
rea. The protocols were approved by the institutional 
review board (IRB) of the Gangnam Severance Hospi-
tal (3-2011-0223) prior to patient enrollment. Written 
informed consent was obtained from each patient 
before the initiation of the lumbar spinal surgery. 
All patients who are waiting for operation schedules 
were screened consecutively at each hospital accord-
ing to inclusion criteria and inclusion criteria were 
as follows: age over 18, patients with degenerative 
lumbar disease who were scheduled for lumbar spinal 
surgery. Baseline demographics data of the 2 groups 
are presented in Table 1.
Patients were divided into 2 groups (patients with 
or without NP). The detailed method is described in the 
instruments section below. For intergroup comparison, 
preoperative diagnosis are categorized into 4 groups: 
lumbar stenosis with segmental instability or without 
instability, herniated lumbar disc, and degenerative 
lumbar scoliosis. We also screened all concomitant 
diseases of patients which could be another source of 
NP such as diabetes mellitus, herpetic zoster, traumatic 
injury, amputation, cancer, stroke, and AIDS.  
2.2. Instruments
2.2.1. Assessment and Diagnosis of Neuropathic 
Pain
NP was diagnosed by using the Leeds Assessment 
of Neuropathic Symptoms and Signs (LANSS) Pain 
Scale, and patients for the NP group were assigned 
with a LANSS pain scale over 12 points. Detailed com-
ponents of this scale are described in Fig. 1. Patients 
were screened using the LANSS scale and divided into 
2 groups before surgery: patients with NP (NP+) or pa-
tients without NP (NP-). Also the Pain Numeric Rating 
Scale (NRS) was used to evaluate pain intensity (1 – 3 
mild pain, 4 – 6 moderate pain and 7 – 10 severe pain). 
2.2.2. Assessment of Health Related Quality of Life 
and Risk Factors for Neuropathic Pain 
Patients’ HRQoL was measured using the following 
general questionnaires: the EuroQoL (EQ-5D), EuroQoL 
Visual Analogue Scale (EQ-VAS), and Short Form-36 (SF-
36). EQ-5D scores ranged from 0 to 1, EQ-VAS and SF-36 
scores ranged from 0 to 100, with higher scores indi-
cating better health status. The EQ-5D consisted of the 
EQ-5D descriptive system and the EQ visual analogue 
and segmental instability are mainly dependent on 
the physician (2) and there are geographic variations 
in the number of spinal procedures also (3). The 
2005 Cochrane review reported limited conclusions 
of surgical efficacy for spinal stenosis because 
of heterogeneity and insufficient evidence (4,5). 
However, 2 multicenter clinical comparative studies 
concluded that surgical intervention for degenerative 
spondylolisthesis and degenerative spinal stenosis 
showed a superior clinical  outcome including both 
pain and health related quality of life (HRQoL) than a 
nonsurgical management (6,7). 
Chronic pain due to lumbar spinal disorders affects 
large numbers of people worldwide and is unquestion-
ably a public health care issue. Neuropathic pain (NP) is 
one type of a refractory chronic pain condition (8). The 
annual incidence of NP has been reported to be 0.82% 
(9) and the prevalence of neuropathic characteristics 
with chronic pain has been reported to be 6.9% in the 
general population (10). The medical treatment for NP 
often fails to relieve pain and symptoms persists. These 
painful conditions often reduce the quality of life and 
limit the activities of daily living (11,12). The health care 
costs for the management of NP are substantial. A re-
cent study in the United States showed that the cost for 
patients with NP was 3-fold that of age- and gender-
matched patients without NP (13). The most common 
locations of chronic NP are the back and legs and 10 
– 40% of patients treated with lumbar spinal surgery to 
reduce their neuropathic radicular pain suffered from 
recurrent or persistent pain (14,15). However there is 
limited evidence about surgical outcomes after lumbar 
spinal surgery in patients with NP or the prevalence 
of NP proportions among patients with degenerative 
lumbar diseases who are candidates for a surgical inter-
vention. The objectives of this study were to investigate 
the prevalence of NP among the patients scheduled for 
lumbar spinal surgery and the relationship between 
HRQoL and NP. We also tried to find out the risk factors 
related to NP and to compare the clinical outcomes and 
the impact on the quality of life after surgical treat-
ment in patients with and without NP. 
Methods
2.1. Study Design and Patients 
This study was a prospective cross-sectional, multi-
center observational study. It was conducted from Sep-
tember 2011 to May 2013 and patients were recruited 
from September 2011 to December 2012. A total of 
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scale (EQ-VAS) and could be used to evaluate surgical 
outcomes of spine surgery (16). The EQ-5D descriptive 
system comprised the following 5 dimensions: mobility, 
self-care, usual activities, pain/discomfort, and anxiety/
depression. Each dimension had 3 levels: no problem 
was scored as one, some problems were scored as 2, 
and severe problems were scored as 3. The EQ VAS was 
designed to assess patients’ self-rated health on a visual 
analog scale (VAS), which ranged from 0 (worst imagin-
able health state) to 100 (best imaginable health state) 
(16). These instruments (LANSS, VAS, EQ-5D, EQ VAS, 
and SF-36) were completed by the participants on the 
day before surgery, and one week and 3 months after 
surgery. 
The patient variables included gender, age, pre-
operative symptom duration, surgical techniques, and 
preoperative diagnosis with regard to the risk factors 
for NP. Surgical techniques were subdivided into instru-
mented fusion and non-instrumented decompression. 
The preoperative diagnosis was classified into stenosis 
with or without instability, herniated lumbar disc, and 
degenerative lumbar scoliosis. Using these patient 
variables, we conducted logistic regression analysis for 
exploring risk factors for NP.
2.3. Statistical Analysis 
All data were analyzed using SAS version 9.2 (SAS 
Institute, Cary, North Carolina). For all analyses, a 
P-value less than 0.05 was defined as statistically sig-
nificant. For the intergroup demographic comparison, 
Students’ t-test was used for variables such as age and 
preoperative duration of symptoms and chi-square 
test was used for variables such as gender, preopera-
tive diagnosis, and concomitant disease. Additionally, 
a logistic regression analysis was used to evaluate the 
relationship between NP and patient variables such as 
gender, age, preoperative symptom duration, surgical 
techniques, and preoperative diagnosis. 
Table 1. Patients’ baseline demographics.
NP+ (N = 404) NP- (N = 705) Total (n = 1109) P-value
Gender, n (%)
0.076   Male 153 (37.9) 306 (43.4) 459 (41.4)
   Female 251 (62.1) 399 (56.6) 650 (58.6)
Age (years)
0.273   Mean (SD) 62.06 (14.2) 61.07 (14.8) 61.43 (14.6)
   Range 21.0 – 87.0 18.0 – 91.0 18.0 – 91.0
Diagnosis, n (%)
   Stenosis w/ instability 64 (15.8) 138 (19.6) 202 (18.2) < 0.001
   Stenosis w/o instability 219 (54.2) 336 (47.7) 555 (50.5) < 0.001
   IVD (disc) 119 (29.5) 224 (31.8) 343 (30.9) < 0.001
   DLS (degenerative lumbar scoliosis) 2 (0.5) 7 (2.0) 9 (0.8) 0.891
Duration of  preoperative symptom (months)
   n 375 681 1056
   Mean (SD) 28.97 (54.87) 35.14 (59.83) 32.95(58.17) 0.176
Concomitant disease, n (%)
   Traumatic injury 10 (2.5) 29 (4.1) 39 (3.5) 0.154
   Amputation 1 (0.2) 2 (0.3) 3 (0.3) > 0.999
   Herpes zoster 4 (1.0) 9 (1.3) 13 (1.2) 0.778
   Diabetes mellitus 52 (12.9) 82 (11.6) 134 (12.1) 0.542
   AIDS 2 (0.5) 0 (0) 2 (0.2) 0.132
   Cancer 11 (2.7) 23 (3.3) 34 (3.1) 0.616
   Stroke 5 (1.2) 10 (1.4) 15 (1.4) 0.802
Students’ t-test was used for variables such as age and preoperative duration of symptoms and chi-square test was used for variables such as gender, 
preoperative diagnosis, and concomitant disease.
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3. Results 
3.1. Intergroup Comparison for Clinical 
Characteristics of Participants
In totally 1,109 patients with 459 (41.4%) men and 
650 (58.6%) women were enrolled in this study. Out 
of 1,109 recruited patients, 404 (36.4%) patients were 
diagnosed as NP+ based on LANSS scale ≥ 12 and 705 
patients were diagnosed and classified as NP- group 
based on LANSS scale < 12. Detailed baseline clinical 
characteristics and demographic data are described 
in Table 1. The mean age was 62.06 years in the NP+ 
group and 61.07 years in the NP- group. The mean pre-
operative symptom duration was 28.97 months for the 
NP+ group, which was shorter than in the NP- group 
with 35.14 months, but without statistical significance 
(P = 0.176). Also there was no statistical significant dif-
ference between groups with regard to gender, age, 
preoperative symptom duration, and the frequency of 
concomitant disease which could be another source of 
NP (Table 1). In terms of preoperative diagnosis, the 
number of patients with lumbar stenosis with instabil-
ity was significantly higher in the NP- group than in the 
NP+ group (15.8% vs. 19.6%), the number of patients 
with lumbar stenosis without instability was signifi-
cantly higher in the NP+ group than in the NP- group 
(54.2% vs. 47.7%), and the number of patients with 
herniated lumbar disc was significantly higher in the 
NP- group than in the NP+ group (29.5% vs. 31.8%). 
3.2. Intergroup Comparison for Surgical 
Outcome including LANSS, NRS, EQ5D, EQ5D-
VAS, and SF-36
The mean LANSS scores of baseline, one week after 
surgery, and 3 months after surgery in the NP+ group 
were higher than in the NP- group (17.44 vs. 6.03, 6.28 
vs. 2.87, and 3.07 vs. 1.95, respectively, P < 0.000). How-
ever, except the baseline score, all mean LANSS scores 
of both groups showed less than 12 during the follow-
up which is adhering to the diagnostic guideline for NP 
(Table 2). With regard to pain improvement, the NRS at 
baseline was significantly higher in the NP+ group than 
in the NP- group (7.50 vs. 7.21, P = 0.018), although NRS 
at one week and 3 months follow-up revealed no sig-
nificant differences between NP+ and NP- (4.00 vs. 3.79, 
P = 0.113, 2.59 vs. 2.81, P = 0.087, respectively, Table 
2). In terms of functional outcomes including HRQoL 
such as EQ5D, EQ5D-VAS, and SF-36, both, EQ5D and 
EQ5D-VAS at baseline implied a worse health status in 
NP+ than in NP- (0.49 vs. 0.55, P = 0.000, 49.88 vs. 56.55, 
P = 0.000, respectively, Table 2). However, during the 
follow-up period, both EQ5D and EQ5D-VAS showed 
no statistical differences between the groups except a 
higher EQ5D at 3 months follow-up in NP+ than in NP- 
(0.86 vs. 0.84, P = 0.029, Table 2). 
Additionally, we performed a SF-36 survey in all pa-
tients at baseline and 3 months follow-up after surgery 
(Fig.1). At baseline survey, NP+ showed consistently 
lower SF-36 scores than NP- in all dimensions except the 
general health dimension, indicating a poorer HRQoL 
preoperatively. Baseline mean scores, obtained on the 
physical component summary (PCS) (34.78) and mental 
component summary (MCS) (52.11) scales of NP + (Fig.1) 
were significantly lower than in NP- (37.86; 55.84, re-
spectively, P < 0.001, Fig.1). At 3 months follow up-after 
surgery, scores of dimensions such as physical function-
ing, role physical, bodily pain, vitality, and emotional 
role were higher in NP+ than in NP-, although the scores 
of dimensions such as general health and social func-
Table 2. Differences in various clinical outcome between 
neuropathic pain (NP+) group and nociceptive pain group 
(NP-)
NP+ (N = 404) 
Mean ± SD
NP- (N = 705) 
Mean ± SD
P-value
LANSS
Baseline 17.44 ± 4.06 6.03 ± 3.52 < 0.001
1 week F/U 6.28 ± 6.48 2.87 ± 3.75 < 0.001
FU 3M 3.07 ± 4.78 1.95 ± 3.41 < 0.001
NRS
Baseline 7.50 ± 1.88 7.21 ± 2.00 0.018
1 week F/U 4.00 ± 2.06 3.79 ± 2.16 0.113
FU 3M 2.59 ± 1.89 2.81 ± 2.13 0.087
EQ5D
Baseline 0.49 ± 0.29 0.55 ± 0.25 < 0.001
1 week F/U 0.76 ± 0.17 0.75 ± 0.18 0.414
FU 3M 0.86 ± 0.16 0.84 ± 0.15 0.029
EQ-VAS
Baseline 49.88 ± 22.13 56.55 ± 20.40 < 0.001
1 week F/U 66.77 ± 16.39 68.43 ± 16.83 0.112
FU 3M 75.84 ± 17.15 74.74 ± 16.17 0.288
Data are mean ± standard deviation. Outcome results at each follow 
up were compared between 2 groups with independent-sample t test. 
LANSS, Leeds assessment of neuropathic symptoms and signs; NRS, 
numeric rating scale; EQ-5D, EQ-5D VAS; NP+, neuropathic pain+; 
NP-, neuropathic pain -.
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tioning of both groups showed no differences. Mean 
scores obtained at 3 months follow-up on the physical 
component summary (PCS) scales of NP+ were signifi-
cantly higher than in NP- (64.45 vs. 61.71, respectively, P 
= 0.009, Fig.1). However, there were no significant dif-
ferences between the mean scores of NP+ and NP- on 
the mental component summary (MCS) scales (67.71 vs. 
67.31, respectively, P = 0.616, Fig.1). 
3.3. Time Course Change of Neuropathic Pain 
Prevalence 
According to the stepwise survey during the follow-
up (Table 3), the overall prevalence of NP has decreased 
during the follow-up period (36.4% at baseline, 8.6% at 
one week follow-up, and 4.0% at 3 months follow-up). 
Of 404 patients with NP, 331 patients (81.9%, 331/404) 
turned into the NP- group which means their LANSS 
scores were lower than 12. Finally at 3 months follow-
Fig.1. Differences in Short-Form 36 (SF-36) data between neuropathic pain (NP+) group and nociceptive pain group (NP-). 
At baseline survey, NP+ showed consistently lower SF-36 scores than NP- in all dimensions except general health dimension, 
indicating a poorer HRQoL preoperatively. At 3 months follow-up after surgery, scores of  all dimensions except general health 
and social functioning were higher in NP+ than in NP-.
Data are mean ± standard deviation. Outcome results at each follow-up were compared between 2 groups with independent-sample t 
test. SF-36, Short-Form 36; NP+, neuropathic pain+; NP-, neuropathic pain-; FU 3M, follow-up at 3 months after operation. * P < 0.05.
up, only 28 patients (6.9%, 28/404) suffered from rem-
nant NP. Of 705 patients (64.6 %) without preoperative 
NP, 22 patients at one week follow-up and 11 patients 
at 3 months follow-up (4.7%, 33/705) showed newly 
developed NP which was probably surgically related. 
However, during the follow-up period, 17 (77.3%) out 
of 22 patients with newly developed NP turned into the 
NP- group although 689 (17 + 672/705, 97.7%) out of 
705 patients without NP preoperatively did not have NP 
at 3 months follow-up after surgery.
3.4. Risk Factor Analysis for Neuropathic Pain 
Logistic regression analysis was conducted for in-
vestigating the relationship between NP and patient 
variables such as demographics (age, gender, and pre-
operative symptoms), surgical techniques (instrumented 
fusion and decompressive laminectomy), and preopera-
tive diagnosis (stenosis with instability, stenosis without 
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instability, herniated lumbar disc, and degenerative 
lumbar scoliosis) (Table 4). None of preoperative di-
agnosis and surgical technique was statistically associ-
ated with NP. Among demographic variables, a longer 
preoperative symptom period was significantly related 
with NP (OR 1.003, P = 0.020, Table 4). 
4. discussion 
We investigated in a multicenter cross-sectional 
observational study with prospective 3 months follow-
up data from 1,109 patients who were scheduled for 
lumbar spinal surgery, the prevalence and its immedi-
ate postoperative change after surgery, and the risk 
factors for NP. To the best of our knowledge, this is the 
first study about the prevalence of NP in surgically in-
dicated patients with degenerative lumbar disease and 
the HRQoL after surgery in patients with NP compared 
to patients with nociceptive pain, although there are 
many articles about epidemiology and incidence of NP 
in patients with chronic low back pain or spinal disor-
der including all the pathology such as cervical disease, 
spinal cord injury, or failed back surgery syndrome 
and its impact on the HRQoL (17-20). Besides that, we 
also conducted a short-term longitudinal prospective 
follow-up survey for the clinical course of NP after sur-
gical treatment.       
NP is a prevalent and often underdiagnosed condi-
tion estimated to affect up to 2% to 3% of the gen-
eral population (18,21-23). Particularly in patients with 
chronic low back pain, the prevalence of NP was much 
higher than in the general population (20,24,25). El Sissi 
W et al (20) reported a 55% prevalence rate among 
1,134 patients with chronic low-back pain in the Ara-
bian Gulf Region assessed using the LANSS scale  and 
Hassan AE et al (24) also published similar results that 
41% of patients with chronic low back pain had scores 
over 12 using the LANSS in the Saudi Arabian popula-
tion. Although, according to Yamashita T et al (25) the 
Table 3. Time course change of  neuropathic pain prevalence.
Baseline (36.4%, 404/1109) 1 week (8.6%, 95/1109) 3 months (4.0%, 44/1109)
NP+ 404 (36.4 %) 
NP+ 73 (18.1%)
NP+ 11 (15.1%)
NP- 62 (84.9%)
NP- 331(81.9%)
NP+ 17 (5.1%)
NP- 314 (94.9%)
NP- 705 (64.6%)
NP+ 22 (3.1%)
NP+ 5 (22.7%)
NP- 17 (77.3%)
NP- 683 (96.9%)
NP+ 11 (1.6%)
NP- 672 (98.4%)
Table 4. Risk factor analysis for neuropathic pain.
Risk Factor OR 95% CI P-value
Demographics
Female (ref. male) 1.291 0.996 – 1.675 0.054
Age 0.997 0.987 – 1.007 0.519
Sx duration 1.003 1.000 – 1.005 0.020*
Surgical Techniques
Instrumented Fusion 0.913 0.668 – 1.249 0.570
Decompressive laminectomy 1
Diagnosis
Stenosis with instability 0.680 0.136 – 3.395 0.778
Stenosis without instability 0.462 0.094 – 2.262 0.147
IVD(disc) 0.518 0.104 – 2.577 0.396
Degenerative Lumbar Scoliosis 1
* P < 0.05, a logistic regression analysis was used to evaluate the relationship between neuropathic pain and candidate variables such as gender, 
age, preoperative symptom duration, surgical techniques, and preoperative diagnosis.
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overall incidence of NP was 53.5% in patients with 
chronic pain related to spinal disorders. These results, 
at a much higher rate than expected, were mainly as-
sociated with cervical spondylotic myelopathy or spinal 
cord injury. They reported an incidence of NP among 
the patients with low back pain of 29.4% and in pa-
tients with spondylolysis or spondylolisthesis of 40.4% 
(25). In our survey, 404 out of 1,109 participants (36.4%) 
were diagnosed with NP according to the LANSS scale 
and these results were similar to previous results more 
specifically compared in degenerative lumbar diseases. 
Attal et al (26) demonstrated that the NP proportion of 
patients with chronic low back pain was the highest in 
those who underwent surgical procedures and postu-
lated that it could be the results of lesions of nocicep-
tive sprouts, postsurgical scars, and local nerve lesions. 
Even in our highly selected patients without a history 
of surgery on their spine, cord injury, and cervical pa-
thology, the prevalence of NP in this study was higher 
than in the general population and similar to results of 
patients in previous articles (20,24,25).  
The impact of NP (of different origin) on HRQoL has 
been the focus of a recent study (12), which reviewed 
52 high-quality published reports on this subject. In 
conclusion the authors found strong evidence that the 
presence (and severity) of NP is associated with greater 
impairments in a number of HRQoL domains. Regard-
less of NP, the HRQoL in patients waiting for spinal or 
musculoskeletal surgery was lower than in the general 
population (27). In the present investigation, EQ5D, 
EQ5D-VAS, and all domain scores of SF-36 in patients 
with NP were significant lower than in patients with 
nociceptive pain at baseline preoperative survey. With 
regard to HRQoL domains dependent on pain, such 
as physical functioning, physical role, and bodily pain, 
absolute values of these domain score were lower than 
40 as expected. However, absolute values of HRQoL 
domains mainly affected by mental components such 
as social functioning, emotional role, and emotional 
health showed relatively higher than physical com-
ponents. Jensen et al (12) reported that weaker asso-
ciations were found between NP and measures of the 
quality of patients’ social relationships than between 
NP and measures of other HRQoL domains. Patients 
with chronic disease processes are able to adapt to their 
physical situation so that their mental function is not as 
affected as their physical function (28,29). Our results 
could be partly explained by the reasons cited above. 
Also the above results indicate that psychosocial and 
behavioral treatments for the mental component of 
NP could be helpful for the improvement of the mental 
HRQoL.  
We conducted this study to confirm the hypothesis 
that patients with NP related to degenerative lumbar 
disorder have poorer surgical results than patients 
with nociceptive pain. Our 3 months follow-up data 
after spinal surgery showed significant improvements 
in both groups. In the physical component summary at 
3 months follow-up, patients with NP had significantly 
higher scores than patients with nociceptive pain even 
though baseline scores are contradictory. However, in 
the mental component summary at 3 months follow-
up, there were no significant differences between the 2 
groups. We conducted a short-term longitudinal study 
for prevalence of NP and found a significant decrease 
at one week and 3 months after surgery. Although 
the incidence rate was similar to the general popula-
tion (2.3 – 6.9%) (10), the recovery rate was relatively 
lower than the disease-related NP with regard to the 
surgical procedure related NP, that is, newly developed 
NP after surgery. There are few references to compare 
those results about the time course change of neuro-
pathic prevalence, thus these results could be useful for 
counseling and informing the patients about surgical 
outcomes or natural history. Krishna et al (30) described 
that complications after posterior lumbar fusion sur-
gery and postoperative neuralgic symptom happened 
in 7.1% of patients. 
In terms of risk factors for NP, we included several 
candidates such as age, gender, preoperative duration 
of symptom, preoperative diagnosis, and surgical tech-
nique. According to the logistic regression analysis, 
female gender and longer duration of preoperative 
symptoms are risk factors for NP. However, age, surgical 
technique, and preoperative diagnosis were not asso-
ciated with NP. Older age, female gender, lower level 
of education, and more disability before surgery are 
reported risk factors in previous articles (31,32). Peul 
et al (33) quantified the relationship between gender 
and rate of recovery and outcome at one year after 
lumbar surgery and found that women showed slower 
recovery rates and higher rates of unsatisfactory results. 
Yamashita T et al (25) reported that advanced age, se-
vere preoperative pain, disease duration over 6 months, 
and a cervical-level lesion are risk factors for NP. Except 
age and level of lesion, their results are consistent with 
our findings. 
This study has several strengths, including the 
highly selected study patients, no drop outs, and the 
longitudinal follow-up of NP prevalence. Despite this, 
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